Sfoglia per Autore
Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl)
1979 Baccarani M.; Gobbi M.; Cavo M.; Tura S.
Assessmen of disease ativity in multiple myeloma with FDG-PET imaging
2004 Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A.
L'imaging del mieloma: la PET-TC nel follow-up del mieloma multiplo
2004 Fanti S.; Cavo M.; Moretti A.; Salizzoni E.; Battista G.; Canini R.
First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma.
2004 Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Palareti G; Tura S; Baccarani M.
Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO).
2004 BAROSI G; BOCCADORO M; CAVO M.; CORRADINI P; MARCHETTI M; MASSAIA M; MERLINI G; TOSI P; TURA S; ITALIAN SOCIETY OF HEMATOLOGY; ITALIAN SOCIETY OF EXPERIMENTAL HEMATOLOGY; ITALIAN GROUP FOR BONE MARROW TRANSPLANTATION.
A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma.
2004 RIA R; VACCA A; RUSSO F; CIRULLI T; MASSAIA M; TOSI P; CAVO M.; GUIDOLIN D; RIBATTI D; DAMMACCO F.
Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
2004 TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M.
Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma
2004 Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A.
New insights into the knowledge of graft-versus-myeloma
2004 M. Cavo
Myeloma therapy: the future is bright
2005 Cavo M.
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants.
2005 GAHRTON G; IACOBELLI S; APPERLEY J; BANDINI G; BJORKSTRAND B; BLADE J; BOIRON JM; CAVO M.; CORNELISSEN J; CORRADINI P; KROGER N; LJUNGMAN P; MICHALLET M; RUSSELL NH; SAMSON D; SCHATTENBERG A; SIROHI B; VERDONCK LF; VOLIN L; ZANDER A; NIEDERWIESER D.
Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma.
2005 TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA S; BACCARANI M.; CAVO M.
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
2005 CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERRAGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY.
International uniform response criteria for multiple myeloma.
2006 Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV;
Proteasome inhibitor bortezomib for the treatment of multiple myeloma.
2006 Cavo M.
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion.
2006 Ambrosini V.; Farsad M.; Nanni C.; Schiavina R.; Rubello D.; Castellucci P.; Pasquini E.; Franchi R.; Cavo M.; Fanti S.
Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results.
2006 Nanni C.; Zamagni E.; Farsad M.; Castellucci P.; Tosi P.; Cangini D.; Salizzoni E.; Canini R.; Cavo M.; Fanti S.
Use of 18 FDG PET/CT to evaluate therapy response of bone myelomatous lesions
2006 C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Cavo; V. Allegri; C. Pettinato; G. Montini; S. Fanti.
Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma
2006 C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G. Montini; M. Cavo; S. Fanti.
The changing landscape of myeloma therapy.
2006 Cavo M; Baccarani M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Chronic lymphocytic leukemia: prognostic factors and stage classification (author's transl) | Baccarani M.; Gobbi M.; Cavo M.; Tura S. | 1979-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Assessmen of disease ativity in multiple myeloma with FDG-PET imaging | Fanti S.; Yu JQ; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P.; Zhuangh H.M.; ...Cavo M.; FRanchi R.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 4.02 Riassunto (Abstract) | - |
| L'imaging del mieloma: la PET-TC nel follow-up del mieloma multiplo | Fanti S.; Cavo M.; Moretti A.; Salizzoni E.; Battista G.; Canini R. | 2004-01-01 | LA RADIOLOGIA MEDICA | - | 1.01 Articolo in rivista | - |
| First-line therapy with thalidomide and dexamethasone in preparation for autologous stem cell transplantation for multiple myeloma. | Cavo M; Zamagni E; Tosi P; Cellini C; Cangini D; Tacchetti P; Testoni N; Tonelli M; de Vivo A; Pa...lareti G; Tura S; Baccarani M. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). | BAROSI G; BOCCADORO M; CAVO M.; CORRADINI P; MARCHETTI M; MASSAIA M; MERLINI G; TOSI P; TURA S; I...TALIAN SOCIETY OF HEMATOLOGY; ITALIAN SOCIETY OF EXPERIMENTAL HEMATOLOGY; ITALIAN GROUP FOR BONE MARROW TRANSPLANTATION. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| A VEGF-dependent autocrine loop mediates proliferation and capillarogenesis in bone marrow endothelial cells of patients with multiple myeloma. | RIA R; VACCA A; RUSSO F; CIRULLI T; MASSAIA M; TOSI P; CAVO M.; GUIDOLIN D; RIBATTI D; DAMMACCO F. | 2004-01-01 | THROMBOSIS AND HAEMOSTASIS | - | 1.01 Articolo in rivista | - |
| Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure. | TOSI P; ZAMAGNI E; CELLINI C; CANGINI D; TACCHETTI P; TURA S; BACCARANI M.; CAVO M. | 2004-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Use of FDG-PET imaging for assessment of disease activity in patients with multiple myeloma | Fanti S.; Yu JQ.; Castellucci P.; Moretti A.; Farsad M.; Nanni C.; Zamagni E.; Cellini C.; Tosi P....; Zhuang HM.; Cavo M.; Baccarani M.; Franchi R.; Salizzoni E.; Canini R.; Monetti N.; Alavi A. | 2004-01-01 | QUARTERLY JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| New insights into the knowledge of graft-versus-myeloma | M. Cavo | 2004-01-01 | BLOOD | - | 1.04 Replica / breve intervento (e simili) | - |
| Myeloma therapy: the future is bright | Cavo M. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. | GAHRTON G; IACOBELLI S; APPERLEY J; BANDINI G; BJORKSTRAND B; BLADE J; BOIRON JM; CAVO M.; CORNEL...ISSEN J; CORRADINI P; KROGER N; LJUNGMAN P; MICHALLET M; RUSSELL NH; SAMSON D; SCHATTENBERG A; SIROHI B; VERDONCK LF; VOLIN L; ZANDER A; NIEDERWIESER D. | 2005-01-01 | BONE MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Neurological toxicity of long-term (>1 yr) thalidomide therapy in patients with multiple myeloma. | TOSI P; ZAMAGNI E; CELLINI C; PLASMATI R; CANGINI D; TACCHETTI P; PERRONE; G; PASTORELLI F; TURA ...S; BACCARANI M.; CAVO M. | 2005-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. | CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERR...AGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| International uniform response criteria for multiple myeloma. |
Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, West...in J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV; |
2006-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Proteasome inhibitor bortezomib for the treatment of multiple myeloma. | Cavo M. | 2006-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. | Ambrosini V.; Farsad M.; Nanni C.; Schiavina R.; Rubello D.; Castellucci P.; Pasquini E.; Franchi... R.; Cavo M.; Fanti S. | 2006-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Role of (18)F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. | Nanni C.; Zamagni E.; Farsad M.; Castellucci P.; Tosi P.; Cangini D.; Salizzoni E.; Canini R.; Ca...vo M.; Fanti S. | 2006-01-01 | EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | - | 1.01 Articolo in rivista | - |
| Use of 18 FDG PET/CT to evaluate therapy response of bone myelomatous lesions | C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Cavo; V. Allegri; C. Pettinato;... G. Montini; S. Fanti. | 2006-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma | C. Nanni; V. Ambrosini; E. Zamagni; M. Farsad; P. Castellucci; M. Sansovini; D. Rubello; G. Monti...ni; M. Cavo; S. Fanti. | 2006-01-01 | THE JOURNAL OF NUCLEAR MEDICINE | - | 4.02 Riassunto (Abstract) | - |
| The changing landscape of myeloma therapy. | Cavo M; Baccarani M. | 2006-01-01 | NEW ENGLAND JOURNAL OF MEDICINE | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile